The mechanism by which ft blockade improves left ventricular dysfunction in various cardiomyopathies has been ascribed to improved contractile function of the myocardium or to improved ,8-adrenergic responsiveness. In this study we tested two hypotheses: (a) that chronic 13 blockade would improve the left ventricular dysfunction which develops in mitral regurgitation, and (b) that an important mechanism of this effect would be improved innate contractile function of the myocardium.
Introduction
Mechanisms available to the heart for compensating longstanding pressure or volume overload include: (a) the FrankStarling mechanism, (b) the development ofmyocardial hypertrophy, and (c) 13-adrenergic stimulation. In longstanding se-the contractile deficit is based at least in part on the loss of force-generating elements in individual cardiocytes (3, 4) . This loss correlates highly with a degree of depression in contractile function in the experimental model (3) .
Of the three types of compensatory mechanisms noted above, the development of hypertrophy in mitral regurgitation is modest comnared with that of other volume overloads and compared to pressure overload (5) (6) (7) (8) (9) (10) (11) (12) (13) . We reasoned that, because it is known that the Frank-Starling mechanism is maximized early in the course of volume overload (14) and since it appears that hypertrophic compensation is limited in mitral regurgitation, a major part of the compensation in mitral regurgitation should be by activation of neurohumoral mechanisms. Indeed, data do show substantial 13-adrenergic support for the failing myocardium in mitral regurgitation (15) . Although activation of these mechanisms may provide shortterm benefit (16) , long-term 13-adrenergic stimulation may be deleterious. This is implied by the fact that (a) catecholamines reduced the viability and protein synthesis in adult isolated cardiocytes (17) and (b) blocking the 13-adrenergic system has been beneficial in other types of heart failure, improving ejection fraction and survival in patients with left ventricular systolic dysfunction (18) (19) (20) (21) . The means by which 13 blockade has been effective in restoring contractile performance in those patients is unclear. Three potential mechanisms include (a) 13 blockade-enhanced responsiveness of a depressed : receptor adenyl cyclase complex allowing enhanced response to endogenous catecholamines (22) (23) (24) , (b) protection of the myocardium from the potential toxic effects of prolonged exposure to high levels of circulating catecholamines (25, 26) thereby improving innate contractile function, and (c) enhanced myocardial performance secondary to the bradycardia induced by 13 blockade.
This study was performed to test two hypotheses. First, we tested the hypothesis that gradually induced 1 blockade would reverse (at least in part) the contractile dysfunction which develops in chronic experimental mitral regurgitation. Second, we tested the hypothesis that a specific mechanism by which this reversal would occur would be "protection" ofthe myocardium from the deleterious effects ofchronic adrenergic stimulation. We would accept this second hypothesis if we found improvement in the contractile dysfunction of cardiocytes isolated from the myocardium of 1-blocked mitral regurgitation dogs in a milieu free of1 agonists. In this situation, enhanced 1 receptor responsiveness could not explain improved contractile function, since there would be no 13 receptor stimulation occurring at the time of cardiocyte evaluation.
Methods

Study design
As shown in Fig. 1 , two groups of six animals were studied longitudinally from baseline when they were normal through 3 mo of chronic mitral regurgitation when previous experience has demonstrated that contractile dysfunction would be present (3, (27) (28) (29) . At that time, one group of dogs was followed for another 3 mo of chronic mitral regurgitation without further intervention. In the second group, # blockade was gradually induced with atenolol after the initial 3 mo of mitral regurgitation and these animals were also followed for 3 mo additionally. Since both groups were followed longitudinally from when they were normal, the animals served as their own controls. Determination ofcatecholamine levels and in vivo contractile function was performed in both groups at baseline, after 3 mo of chronic mitral regurgitation, and after 6 mo of chronic mitral regurgitation. 1 wk after the 6-mo studies, the animals were humanely killed under deep anesthesia. Isolated viable cardiocytes were disaggregated from the myocardium and studied in vitro (3, 30, 31) by investigators blinded to the in vivo results. Contractile function of the washed cells were assessed in a milieux free ofcatecholaminesby examination ofpeak unloaded sarcomere shortening velocity and by examining the viscosity-velocity relationship of these cells (31) . Briefly, increasing the viscosity of the milieu of a contracting cardiocyte effectively afterloads the cell; as such the viscosityvelocity relationship of the cardiocyte is analogous to the force-velocity relationship of classic cardiac muscle mechanics.
Additionally, cardiocyte morphometric analysis was performed on a second portion of the myocardium that had been fixed-perfused at the time of removal of the heart.
Assessment ofin vivo contractilefunction
In vivo contractile function was assessed in these experiments using the mass-corrected slope of the end ejection stress-volume relationship and the end systolic stiffness constant (28, 32, 33) . Although all indexes of in vivo function have their limitations, these two indexes have been investigated extensively by us and by others and their limitations are relatively well known. They have correlated well in the past with an independent standard of contractile function-sarcomere function in isolated cardiocytes (3) . The slope of the end ejection stress-volume relationship has been shown to be sensitive to changes in contractile state (27) . Because it is also substantially affected by changes in cardiac mass and size (the slope must go down as the heart gets bigger regardless of contractile function) (34, 35) , we corrected the slope for the mass present at the time of study. Thus as the hearts enlarge reducing the slope, at the same time mass increases and multiplying by mass offsets the decline in slope. We also examined end systolic stiffness which is derived from systolic stress-strain analysis. Since strain is a dimensionless property, this index is independent of size (32); it correlates well with changes in contractile function (32).
Without further intervention, at 6 mo we would have studied one group of dogs during , blockade (the chronically blocked group) while the other group would have been studied during full native adrenergic stimulation which could have obscured an in vivo contractile deficit in that group (15) . Because of this confounding influence, all determina- tions of in vivo contractile function at all times of study were performed during acute # blockade with esmolol (27-29). In effect, acute # blockade "leveled the playing field" for studying contractile function in vivo. Obviously in the chronically blocked group, the addition of the acute # blockade would be expected to have no effect. This infusion was administered in the chronically blocked group to confirm that the animals were indeed U-blocked (by virtue of a lack of change in hemodynamics) and to maintain identical experimental conditions between the two groups. The data used to construct the indexes ofcontractile function were obtained from simultaneously recorded pressure and volume data (from which stress could be derived) taken from multiple, variably loaded beats during cineangiography (27-29, 32, 33). During cineangiography an inferior vena cava balloon which had been inflated was deflated producing a beat by beat increase in both volume and pressure allowing construction of the indexes. The data were obtained as follows. The animals were lightly anesthetized by a combination of droperidol fentanyl given intravenously and inhaled nitrous oxide (N20/ 02 ratio of 3:1). This combination of anesthetics has been demonstrated to have little effect on contractile function (36) . A cutdown was performed over the cervical vessels; the jugular vein and carotid artery were isolated. A Swan-Ganz catheter was introduced into the jugular vein and advanced to the pulmonary artery for the purposes ofmeasuring intracardiac pressures and recording thermodilution forward cardiac output. The inferior vena cava balloon was also inserted into the same vein. A pigtail catheter was advanced to the left ventricle from the carotid artery for the purpose of contrast injection and for recording left ventricular pressure via a mercury-calibrated fluid-filled transducer. An externally calibrated high-fidelity Millar catheter was also inserted through the carotid artery into the left ventricle where it was matched to the mercury-calibrated pressure tracing. Acute IB blockade was induced by infusion of esmolol 1.5 mg/kg over 3 min followed by constant infusion at 0.3 mg/kg per min for the remainder ofthe study.
After # blockade was accomplished, a left ventriculogram was performed in the 300 right anterior oblique projection using nonionic contrast media. This ventriculogram was used to calculate cardiac volumes, mass, and ejection fraction. After a 15-min recovery period, a "contractility" ventriculogram was performed using the inferior vena cava balloon to vary pressure and volume as described above to develop the contractile indexes.
These procedures were followed identically in every animal at each of the three observation periods. In the initial study, mitral regurgitation was then created. In the acute studies and those at 3 and 6 mo of mitral regurgitation, the catheters were then withdrawn, the vessels repaired and the animals recovered under veterinarian supervision. Animals were observed daily for signs ofheart failure and heart rate was recorded twice weekly. At Chronic d3 blockade Chronic # blockade was induced by the administration of oral atenolol in gradual increments. Starting with 12.5 mg daily the dose was increased by 12.5 mg every 2 wk until a total dose of 50 mg per day was given. The effectiveness of (3 blockade was then tested by infusion of isoproterenol at a dose of 4.0 ,g/kg per min. In every case this dose of isoproterenol failed to increase heart rate by more than five beats per minute indicating near-total (3 blockade. The presence of (3 blockade was further proven in the atenolol group when the acute infusion of esmolol during the 6-mo in vivo study failed to lower heart rate or cardiac output in any animal receiving chronic f3 blockade.
We are aware that the canine myocardium contains both l,, and 2
receptors. In human heart failure, (2 receptors Contractilefunction ofcardiocytes studied in vitro 1 wk after the final determination of in vivo contractile function, the animals were deeply anesthetized. After a thoracotomy was performed, the hearts were removed quickly and placed in a calcium-free buffer of the following composition (mM): NaCl 130.0, KC1 4.8, MgSO4 1.2, NaH2PO4 1.2, NaHCO3 2.5, Hepes buffer 12.0, and glucose 12.5; 6 mg/liter insulin was also added. The atria and great vessels were next removed, leaving the left circumflex coronary artery intact. A wedge of left ventricular free wall perfused by either the first or second branch of this artery was then dissected free of the heart, the arterial branch was cannulated, and the specimen was cleared of blood by brief perfusion with buffer warmed to 37°C and gassed with 100% 02. To dissociate the cardiocytes from the tissue, perfusion was continued for 15 min at 37°C by recirculating the buffer, now supplemented with 155 U/ml type II collagenase and 10 ,M Ca2"; mean pressure (-80 mmHg) and pH (-7.40) were kept within the physiological range. Any undissociated portions ofthe specimen, primarily the borders and epicardium, were then discarded. The remaining collagenase-perfused tissue was placed in fresh enzyme-containing buffer, to which was added 3% saltfree bovine serum albumin and 300 ,uM Ca2+, and minced into -2-mm cubes. The minced tissue was then gently agitated for 5 min at 37°C while being gassed with 100% 02. The cardiocytes were harvested by drawing offthe supernatant in which they were suspended for filtration through 2 10-,gm nylon mesh. They were kept for 1 h at 370C and pH 7.4 in collagenase-free buffer supplemented with 2.5 mM Ca2" before defining contractile function. The use of laser diffraction techniques for measuring sarcomere motion in isolated cardiocytes is well established (40, 41 ). An aliquot of isolated cardiocytes was added to 4 ml of the 2.5 mM Ca2" buffer in a well affixed to a glass slide. The cardiocytes came to rest on the bottom of this chamber, which was placed on the stage of an inverted micro- Inclusion of methylcellulose in the cardiocyte superfusate was used to impose graded external loads on the cells during contraction, as we have described in detail before (31) . Briefly, 2% solutions ofmethylcellulose of increasing polymer length were prepared in the standard 2.5 mM Ca2" buffer. The viscosity of each methylcellulose solution was measured at 370C by both a Brookfield viscometer and by falling ball viscometry (42) ; the two techniques produced identical results. To be sure that contractile function (43, 44) and morphology (45) were not affected by potential osmotic changes in the viscous solutions, the osmolarity of each methylcellulose solution was measured by both equilibrium vapor pressure and freezing-point depression. The osmolarity of the standard buffer was 290±5 mosM/kg, and as would be expected for 2% solutions of very large molecules, this value did not increase significantly in any of the methylcellulose solutions.
Sarcomere motion was characterized as described before (31) . The cardiocytes (five left ventricular cells from each of seven control dogs and five left ventricular cells from each of 10 mitral regurgitation dogs) were stimulated to contract at 0.25 Hz either in the standard l-centipoise buffer or in buffer-methylcellulose solutions of known viscosities ranging from 12 to 500 centipoise. When the extent of shortening was stable after 10-15 contractions, 10 contractions were sampled and averaged to yield a final profile ofsarcomere length and velocity versus time during contraction. Only cardiocytes with the following characteristics were analyzed: single, rod-shaped cells unattached to adjacent cells, which contracted with each stimulus and were quiescent between stimuli. To apply a viscous load to contracting cardiocytes, the cells were immersed in superfusates of differing viscosities. Superfusate viscosities (at 370C) of 1, 12, 160, and 500 centipoise were used in studying the cardiocytes from each left ventricle; they were applied in random sequence to prevent any systematic sampling bias, and each cell was studied at all four viscosities.
Morphometric analysis
A region of the left ventricular free wall (8 x 8 cm) was perfused via the anterior descending artery with a buffered sodium cacodylate solution containing 2% paraformaldehyde, 2% glutaraldehyde solution (pH 7.4, 325 mosM) for 20 min using a perfusion pressure of 100 mmHg (46) . After perfusion, this region was finely minced, placed in additional fixative for 3 h, and then prepared for electron microscopy. From the remainder of the left ventricular free wall, three full-thickness sections (2 x 2 cm) were taken, immersed in 10% buffered formalin for 3 h, and prepared for light microscopic examination.
Light microscopy. The tissue was processed for light microscopic examination through graded ethanols, cleared in xylenes, and embedded in paraplast. Slices 4 um in thickness were cut from the blocks and mounted on glass slides and stained with hematoxylin and eosin for morphometric analysis. These sections were mounted on an inverted microscope (IM-35, Ziess, Munich, Germany) and circumferentially oriented cardiocytes were imaged using an epiflorescence illuminator with a rhodamine filter at a magnification of 630X (46, 47) . By using this approach, cardiocyte diameter could be determined in situ and used for subsequent cardiocyte volume computations. Three slices at 1, 2, and 3 mm deep from within each tissue block were examined. By using this method, nine full-thickness sections from the left ventricle of each animal were examined.
Left ventricular sections from the present study were also prepared in order to examine the morphology of the capillary bed. and the capillary density within the myocardium was determined as previously described (8, 49) . The lectin (Sigma Chemical Co., St. Louis, MO) conjugated to horseradish peroxidase was incubated on the tissue sections as described previously. The stained left ventricular sections containing circumferentially oriented capillaries were imaged at a final magnification of 400x. For each left ventricular section, 10 random fields with an area 25,390 gm2 per field were analyzed. By using computer aided stereology, the number ofcapillaries per unit area (numerical density) within the myocardial sample was computed as previously described (48) (49) (50) .
Electron microscopy. Tissue sections were prepared for electron microscopy using methods described by this laboratory previously (46, 47) . Six tissue blocks in the circumferential orientation from the left ventricle ofeach dog were then used to obtain thin sections for electron microscopy. Three grids, containing three thin sections each, were prepared from each block. Thin sections were stained with uranyl acetate and lead citrate and examined with a model IOOS electron microscope (JEOL USA, Peabody, MA). The central portion of each section was photographed at a calibrated magnification of 10,000. These electron micrographs were then coded and this code was not broken until the completion of the study. From the circumferentially oriented micrographs, the percent volume of myofibrils within cardiocytes was analyzed morphometrically by using a stereology sampling grid consisting of 140 sampling points (46) (47) (48) .
Regional variability of the percent volume of myofibrils was also studied in two dogs with mitral regurgitation not receiving (3 blockade. We felt that since the pathology would be the most disordered in these dogs, variability would be greater here. Samples were taken from the apex, midwall, and base from both the endocardium and epicardium for comparison.
The total left ventricular myocardial volume was computed by dividing left ventricular weight by the specific gravity of muscle tissue: 1.06 g/ml (46, 51) . The total volume of left ventricular myofibrils was computed as the product of total myocardial volume and the percent volume of myofibrils. Total mitochondrial volume was computed in identical fashion.
Cardiocyte examination. Cardiocytes were isolated by using methods described above (3, 30) . Isolated cells (5 x I04 cells/ml) were then immediately transferred into electron microscopy fixative solution. The isolated cardiocytes were imaged using a x 10 phase contrast objective. The image was input into the image analysis system and the images were digitized at 512 X 512 line resolution and 256 gray levels. Individual cell profiles were automatically discriminated by gray level in order to determine cardiocyte length, width, and profile surface area (46, 47) . The volume of the digitized cardiocyte profile was then computed using methods previously described (46, 52) . Briefly, the cardiocyte was digitally sectioned into l-tim increments perpendicular to the long axis of the cell. The volume of each of these segments was then computed based upon a cylindrical frame of reference. Total cardiocyte volumes were estimated as the sum ofthese individual volumes of rotation about the long axis ofthe cell and also by using the average cell diameter obtained from the myocardial sections analyzed (46, 52) . From this computed isolated cardiocyte volume, the cardiocyte myofibril and mitochondrial volumes were determined using the volume percent of myofibrils and mitochondria determined from the electron microscopic examination.
Calculations
Volumes were determined using the area length method. Left ventricular mass was determined using Rackley's method (53), previously demonstrated to be accurate as used in our laboratory (27). Wall stress (a) was calculated from Mirsky's formula (54). The end systolic stiffness constant, k, was determined by solving the equation
for k, where C is a constant, and the natural logarithm of 1/H (the inverse of wall thickness) is the strain term in this stress strain analysis of systolic stiffness (32). The slope of the end ejection-stress volume relationship was determined by linear regression. As in previous studies, we used end ejection volume matched to end systolic pressure. Although end ejection and end systole are not synonymous in mitral regurgitation, we have used end ejection volume because (a) it is clearly definable, (b) little ejection occurs after aortic valve closure in mitral regurgitation, and (c) these data have correlated well to the more laborious isochronally derived E.. values in previous studies (28) . Regurgitant fraction (RF) was defined as:
RF SVt -SVF SRVt where SVt = total stroke volume (angiographic end diastolic volume -end systolic volume) and SVF = forward stroke volume (thermodilution cardiac output/heart rate).
Statistics
Data are expressed as mean± 1 SE. Differences between groups and differences between parameters studied at different time points within the same group were inferred by two-way analysis ofvariance followed by a Newman-Keuls test if ANOVA testing demonstrated that differences were present.
Results
Heart rate in the conscious state at baseline was 91±5 beats/ min in the unblocked group and 92±6 beats/min in the group that eventually received ,3 blockade. After 3 mo ofmitral regurgitation, heart rate had increased similarly in both groups (138±6 beats/min in the unblocked group, 137±6 beats/min in the eventually blocked group). After (3 blockade was instituted, heart rate fell significantly, 119±4 beats/min once atenolol reached its maximum dose, whereas heart rate was unchanged, 136±5 in the unblocked group (P < 0.05). Before the institution of ,3 blockade after 3 mo of mitral regurgitation, all animals in both groups manifested tachypnea as a sign of heart failure during at least an observation period. After institution of atenolol in the i3 blockade group, this sign was no longer detected in five of the six dogs. Fig. 2 demonstrates that severe mitral regurgitation was created and maintained in both groups of dogs as indicated by MR, mitral regurgitation; (-blocked MR, the group receiving atenolol; unblocked MR, the group ofdogs with mitral regurgitation that did not receive atenolol. Figure 3 . End diastolic volume is shown for both groups throughout the study. In both groups, end diastolic volume nearly doubled. There were no differences between groups at any time period. The abbreviations are the same as in Fig. 2. regurgitant fraction of 60%. Thus, both groups of dogs experienced similar severe volume overload. Fig. 3 demonstrates that this similar volume overload produced a similar increase in end diastolic volume which increased in the unblocked group from 74±3 ml to 139±14 ml after 6 mo and increased from 71±7 to 127±9 ml in the 3-blocked group. As a prerequisite for supposing that adrenergic overstimulation might cause left ventricular dysfunction, it had to be demonstrated that catecholamines were elevated. Fig. 4 demonstrates norepinephrine levels in the two groups ofdogs. In both groups, plasma norepinephrine increased significantly and by > 100%. Fig. 5 demonstrates left ventricular mass normalized to body weight for the two groups. After 3 mo of mitral regurgitation, the left ventricular to body weight ratio increased similarly by -45%. However, in the unblocked group ofdogs with mitral regurgitation, this ratio plateaued and did not increase further. Conversely, in the 13-blocked group LVBW continued to increase such that it was significantly higher at 6 mo than it had been at 3 mo (5.04±0.36, 3 mo vs. 6.18±0. 48 < 0.05) and also was significantly higher than that of the unblocked group. Body weight did not change in either group during the study. Fig. 6 demonstrates changes in pulmonary capillary wedge pressure. It was similarly elevated in both groups after 3 mo of mitral regurgitation. However, it then fell significantly at 6 mo in the 13-blocked group while no reduction occurred in the unblocked group. Fig. 7 demonstrates the changes in two indexes of contractile function. Both were similarly and severely depressed after 3 mo ofchronic mitral regurgitation. In the unblocked group this depression persisted for the next 3 mo. However, in the group that received atenolol, there was substantial improvement in both indexes compared to 3 mo of mitral regurgitation and compared to the unblocked group. While mass-corrected end ejection stress-volume relationship was still mildly depressed in the 13-blocked group compared to baseline, end systolic stiffness (k) returned to the baseline value. Contractility data from the isolated cardiocytes are shown in Fig. 8 . There was an excellent correlation between the in vivo index of contractile function (end systolic stiffness, k) and unloaded sarcomere shortening velocity. With one excep- tion the 1-blocked dogs fell upward and to the right of the unblocked dogs demonstrating improved contractile function compared to the unblocked group, both in vivo and in vitro. In the right hand panel of this figure, the cardiocyte velocity-viscosity relationship is demonstrated for normal dogs, for the 1-blocked mitral regurgitation dogs and for the unblocked mitral regurgitation dogs. The cardiocytes from the ,3-blocked mitral regurgitation dogs were slightly depressed compared to those from normal dogs only in the unloaded state. At other viscosities contractile function was similar to cells from normal dogs. However, the sarcomere shortening velocity of cardiocytes from the unblocked dogs was depressed at all viscosity levels except for 500 cps. Cardiocyte morphometric data are demonstrated in Table  I . Cardiocyte length was increased in both mitral regurgitation groups. Capillary density was not reduced consistent with previous work demonstrating normal coronary blood flow and flow reserve in this model (29) . Importantly, the percentage of the cell comprised by myofibrils was reduced from 64±2% in normals to 39±2% in the unblocked group (P < 0.05). The magnitude of this reduction was consistent between the endocardium and epicardium and among sections taken from the base, midwall, and apex. In the 13-blocked group, there was a substantial increase in the percentage of the cell comprised by myofibrils to 55±4% (P < 0.05). Improvement in myocardial architecture can be seen in Fig. 9 .
Discussion
There were three major findings ofthis study. First, blockade substantially ameliorated the contractile dysfunction caused by chronic experimental mitral regurgitation. To our knowledge this is the first time that blockade has been demonstrated to be efficacious in the treatment ofcontractile dysfunction due to valvular heart disease. Second, we demonstrated that at least one mechanism by which restoration in contractile function occurred was improvement in the function of isolated cardiocytes. This occurred in the absence of receptor stimulation. (58) (59) (60) . Injury also occurs when isolated adult cardiocytes are exposed to high doses of catecholamines (17) . These data suggest the chronic 13 13 blockade was effective in these studies by "protecting" the myocardium from chronic 13-adrenergic overstimulation. The exact mechanism of this protection remains to be elucidated. A third mechanism by which 13 blockade could be effective (and which remains unexplored) is that of 13 blockade-induced reduction in heart rate. Indeed, in this study, heart rate fell significantly in the 1-blocked group. Reduced heart rate could restore contractility by reducing energy utilization, by reducing cellular injury due to calcium influx (61) or by restoring the ventricle to a more effective position on its force-frequency curve (62) .
In the current study, 1 blockade was associated with increased cardiac muscle mass. Increased myocardial mass must have been due at least in part to the restoration of myocardial contractile elements which we observed. Although catecholamines have been noted to be trophic in vitro in neonatal cardiocytes (63) , catecholamines decrease protein synthesis in adult cardiocytes (17) . We suspect that in our in vivo model 13 blockade permitted the increase in left ventricular mass by allowing load-induced cardiac hypertrophy to occur under protection from catecholamine toxicity.
Limitations. In this study we did not examine 13 receptor function. Thus, it is entirely possible and in fact likely that 1 receptor up-regulation and improvement in responsiveness to 13 receptor stimulation played some role in the improvement in the contractile function that we found in vivo. However, our correlation data suggest that much of the improvement in contractile function which we observed can be explained by improvement of contractility of the cardiocytes themselves which occurred in the absence of13 stimulation. This in turn was associated with the restoration of contractile elements suggesting that was a major mechanism of improvement seen in this study.
Obviously in this longitudinal study, we could not weigh the hearts directly at each observation period without killing the animal. Thus our mass measurements had to be calculated from angiographic data. However, in our hands such data have correlated extremely well with actual weight in the past (27).
Finally, our cell volumes were computed rather than directly measured by the Coulter Counter technique. However, in the past, the methods which we used have been in good agreement with the Coulter Counter technique (64) .
Conclusions. We conclude that gradually induced (3 blockade substantially improves the contractile dysfunction that occurs secondary to chronic experimental mitral regurgitation. Restoration of contractile function was based on restoration of contractile elements in isolated cardiocytes, which in turn led to improved ventricular function.
